MyoKardia (MYOK) Reports Q2 Loss of $0.41/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
MyoKardia (MYOK) Prices 3.5M Share Offering at $35/Sh
August 9, 2017 5:54 AM EDTMyoKardia, Inc. (NASDAQ: MYOK) today announced the pricing of an underwritten public offering of 3,500,000 shares of its common stock at a public offering price of $35.50 per share, before underwriting discounts. In addition, the underwriters have a 30-day option to purchase an additional 525,000... More
MyoKardia (MYOK) PT Raised to $48 at Wells Fargo
August 7, 2017 10:34 AM EDTWells Fargo raised its price target on MyoKardia (NASDAQ: MYOK) to $48.00 (from $31.00) while maintaining a Outperform rating.
Analyst Jim Birchenough comments "We believe results were better than expected and should bode well for phase 3 success in the planned EXPLORER study. We... More
